Cost-effectiveness of scaling up of hepatitis C screening and treatment: a modelling study in South Korea
Background The prices and the coverage of effective direct-acting antivirals (DAAs) to treat hepatitis C vary across countries. South Korea expanded DAAs coverage through national health insurance. This study aims to analyse the cost-effectiveness of scale-up of hepatitis C screening and treatment w...
Saved in:
| Main Authors: | Rifat Atun, Jungyeon Kim, Markus Haacker, Salmaan Keshavjee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-06-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/4/3/e001441.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experiences of Growing Up with Mothers with Schizophrenia in South Korea: A Qualitative Study
by: Soyoung Shin, et al.
Published: (2024-12-01) -
Correspondence to editorial on “Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study”
by: Chang Hun Lee, et al.
Published: (2024-10-01) -
Elimination of viral hepatitis: How far are we?: Editorial on “Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study”
by: Eun Ju Cho
Published: (2024-10-01) -
Cost-effectiveness and budget impact analysis of facility-based screening and treatment of hepatitis C in Punjab state of India
by: Radha K Dhiman, et al.
Published: (2021-02-01) -
Modelling the impact of rapid diagnostic tests on Plasmodium vivax malaria in South Korea: a cost–benefit analysis
by: Jun Yong Choi, et al.
Published: (2021-02-01)